HR-MAS NMR Tissue Metabolomic Signatures Cross-Validated by Mass Spectrometry Distinguish Bladder Cancer from Benign Disease

Effective diagnosis and surveillance of Bladder Cancer (BCa) is currently challenged by detection methods that are of poor sensitivity, particularly for low-grade tumors, resulting in unnecessary invasive procedures and economic burden. We performed HR-MAS NMR-based global metabolomic profiling and...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Tripathi, Pratima, Somashekar, Bagganahalli S, Ponnusamy, M., Gursky, Amy, Dailey, Stephen, Kunju, Priya, Lee, Cheryl T., Chinnaiyan, Arul M., Rajendiran, Thekkelnaycke M., Ramamoorthy, Ayyalusamy
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2013
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3722911/
https://ncbi.nlm.nih.gov/pubmed/23731241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/pr4004135
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller